About
Small Molecules
Areas of Focus
Categories
Small Molecule PharmaceuticalChina
Clinical Trials (9)
View allTotal Trials
9
As Lead Sponsor
9
As Collaborator
0
Total Enrollment
1,615
By Phase
PHASE1: 4PHASE3: 3PHASE2: 2
By Status
COMPLETED: 5RECRUITING: 4
Clinical Trials Pipeline9 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT06997484Lead Sponsor
First-in-Human Single and Multiple Dose of HL-400
PHASE1Recruiting
54 participants
Started: Apr 25, 2025 · Completed: Feb 27, 2026
NCT06887127Lead Sponsor
A Long-term Extension Clinical Study of TLL-018 in Patients With Rheumatoid Arthritis
PHASE3Recruiting
350 participants
Started: Mar 10, 2025 · Completed: Dec 31, 2027
NCT06396026Lead Sponsor
A Study of Efficacy and Safety of TLL-018 in CSU Participants
PHASE3Recruiting
436 participants
Started: Dec 24, 2024 · Completed: Dec 30, 2027
NCT06020144Lead Sponsor
A Phase 3 Study Comparing TLL-018 to Tofacitinib in RA Subjects With Inadequate Response or Intolerance to bDMARDs
PHASE3Recruiting
450 participants
Started: Nov 15, 2023 · Completed: Sep 30, 2025
NCT05945810Lead Sponsor
Evaluation of TLL-018 Extended and Immediate Release Formulation for Bioequivalence Testing in Healthy Chinese Subjects
PHASE1Completed
28 participants
Started: Jul 12, 2023 · Completed: Aug 28, 2023
Locations (1)
Headquarters
Hangzhou, China
Map
Loading map...